openPR Logo
Press release

RFA President Expects Accelerated Renewable Fuels Standard to Pass in December

11-27-2007 01:45 PM CET | Energy & Environment

Press release from: Ethanol Statistics

Ethanol Statistics

Ethanol Statistics

Although he thinks that “Washington is a dysfunctional place right now, in which it is far more easy to stop legislation than to pass legislation,” RFA President and CEO Bob Dinneen remains “pretty optimistic that they (the Senate) will be able to get an energy bill done in December”.

“$96 per barrel of oil is a powerful motivator for congress to act” Mr. Dinneen told Ethanol Statistics in an exclusive interview, “and people are very concerned that congress is not taking definitive action to address that tremendous challenge”. Mr. Dinneen refers to a poll released a few weeks ago showing that 74% of Americans want the United States to utilize greater volumes of renewable fuels like ethanol and biodiesel, and more than 80% want the government to be actively engaged in promoting policies that support that.

“The congress reads those polls and I am reasonably confident, as much as anybody can be confident about legislative action in Washington today, that there will be an energy bill before the end of the year.” adding “I think it will happen sometime in December, and I am very confident that if there’s an energy bill, it will include an accelerated and an expanded Renewable Fuels Standard. One that is largely focussed on cellulose.”

In the interview, Mr. Dineen provides an outlook to 2008. He talks about the E10 blend wall and the EPA study on higher blends, flex-fuel vehicles and development of infrastructure and upcoming legislation such as the energy bill. Additionally, he explains why consumption of ethanol is lagging behind on production.

The entire interview, titled ‘RFA President Confident About Ethanol in 2008’ can be found on

http://www.ethanolstatistics.com/Expert_Opinions/RFA_President_Confident_About_Ethanol_in_2008_291107_1.aspx

Ethanol Statistics
P.O. Box 5058
3301 CB Dordrecht
The Netherlands

Please contact Rob Penne
r.penne@ethanolstatistics.com
+31 6 5432 5588

Ethanol Statistics is a European market research and business information publisher. Through its website, it provides professionals in the ethanol industry the latest ethanol news, commodity prices, expert opinions and market analyses

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RFA President Expects Accelerated Renewable Fuels Standard to Pass in December here

News-ID: 32920 • Views:

More Releases from Ethanol Statistics

European fuel ethanol association eBIO assesses the most controversial biofuel issues
European fuel ethanol association eBIO assesses the most controversial biofuel i …
In its bi-monthly market commentary at Ethanol Statistics, European fuel ethanol association eBIO tackles the most controversial issues in the decision-making process on EU biofuels legislation. The debate in the European Union on crucial legislation for the biofuel industry is entering a decisive phase. A number of sensitive issues still need to be resolved. Putting aside all the nitty-gritty there are 2 major items left, according to eBIO, which are
Ethanol Statistics now offers a 15% discount on the Monthly Market Review
Ethanol Statistics now offers a 15% discount on the Monthly Market Review
Companies and professionals that are active in the Ethanol Industry, whether it is in production, R&D, financial services, chemicals, storage and transportation or otherwise, can now get a 15% introductory discount if they subscribe to the Ethanol Statistics – Monthly Market Review before June 1st. The Monthly Market Review (or MMR) provides professionals in the ethanol industry with the latest industry news, conveniently sorted by region; comprehensive price analyses of
Cellulosic ethanol development is partly underfunded
Cellulosic ethanol development is partly underfunded
The product development phase in cellulosic ethanol research and development is relatively underfunded compared to other phases. That is the conclusion of the cellulosic ethanol focused analysis section in the march edition of the Ethanol Statistics – Monthly Market review. The analysis identifies roughly three development stages prior to commercial-scale production: (1) Basic discovery and R&D, (2) Product development and (3) Pilot/Demonstration plants. Figure 1 visualizes the funding gap that
Worldwide cellulosic ethanol production in 2020 at least 16.5 billion gallons
Worldwide cellulosic ethanol production in 2020 at least 16.5 billion gallons
The worldwide production of cellulosic ethanol will amount to at least 16.5 billion gallons in 2020, if the targets set in the United States, China, Europe, Japan and Brazil are achieved. Based on currently proposed and signed legislation, the United States would account for over 63.9% of that market, while the EU and China would account for 10.4 and 11.5% respectively. Although Brazil doesn’t have any official legislation on cellulosic

All 5 Releases


More Releases for RFA

Endoscope + Radiofrequency Ablation (RFA) Market Expected to Reach $7,471 Millio …
Endoscope + radiofrequency ablation (RFA) market was valued at $3,567 million in 2017 and is projected to reach $7,471 million by 2025, growing at a CAGR of 9.6% from 2018 to 2025. North America was the highest revenue contributor in 2017 and is expected to maintain this trend throughout the forecast period. Radiofrequency ablation (RFA) utilizes thermal energy to accomplish targeted tissue destruction. RFA was initially studied for the treatment of
Endoscope + Radiofrequency Ablation (RFA) Market 2022 | Detailed Report- Boston …
The Endoscope + Radiofrequency Ablation (RFA) report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry. The Endoscope + Radiofrequency Ablation (RFA) report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides
Endoscope + Radiofrequency Ablation (RFA) Market Emerging Trends in COVID-19 Out …
Allied Market Research published a new report, titled, "Endoscope + Radiofrequency Ablation (RFA)” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Covid-19 Impact on
Endoscope + Radiofrequency Ablation (RFA) Market Offer Lucrative Growth Opportun …
Radiofrequency ablation (RFA) utilizes thermal energy to accomplish targeted tissue destruction. RFA was initially studied for the treatment of dysplastic Barrettes esophagus (BE) within the gastrointestinal (GI) tract, and this is still considered to be a common application of RFA. In addition, the indications for endoscopic RFA continue to evolve. Endoscope + Radiofrequency Ablation (RFA) Market was valued at $3,567 million in 2017 and is projected to reach $7,471 million by
Endoscope - Radiofrequency Ablation (RFA) Market 2019 will Boom By Key Players B …
Endoscopic RFA is an advanced treatment modality, which is commonly applied in the treatment of medical indication such as uncoordinated heartbeats, Barrett's esophagus, and pain management, and others. Radiofrequency ablation is considered to be an FDA-approved advanced endoscopic technique in which the diseased tissue is exposed to heat energy for its destruction or removal. The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567.4 million in 2017 and
Endoscope + Radiofrequency Ablation (RFA) Market by Application (Cardiology, App …
Endoscopic RFA is an advanced treatment modality, which is commonly applied in the treatment of medical indication such as uncoordinated heartbeats, Barrett's esophagus, and pain management, and others. Radiofrequency ablation is considered to be an FDA-approved advanced endoscopic technique in which the diseased tissue is exposed to heat energy for its destruction or removal. The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567.4 million in 2017 and